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Ketenes were generated by the thermolysis of alkoxyalkynes
under flow conditions, and then trapped with amines and
alcohols to cleanly give amides and esters. For a 10 min reac-
tion time, temperatures of 180, 160, and 140 °C were re-
quired for 95% conversion of EtO, iPrO, and tBuO alk-
oxyalkynes, respectively. Variation of the temperature and
flow rate with inline monitoring of the output by IR spec-
Introduction
Flow chemistry has traditionally been seen as a tool in
process chemistry where the safety aspects and ease of
scale-up outweigh the effort involved in the optimisation of
a reaction to work well under flow conditions.[1] There is
increasing recognition that the flow method also has an im-
portant role in discovery chemistry,[2] particularly where the
formation of an intermediate may be optimised before it
goes on to react with a wide variety of substrates to gener-
ate a library of compounds. Flow chemistry has the advan-
tage that temperatures well above the normal boiling point
of solvents can be used safely, due to its excellent high-
pressure capability. This makes the thermal generation of
reactive intermediates attractive. We are interested in the
use of flow chemistry to rapidly carry out a number of reac-
tions under precisely controlled conditions with inline mon-
itoring of outcomes, to allow fast study[3] and optimisation
of processes.
The reaction we chose to investigate was the generation
of ketenes by thermal sigmatropic rearrangement of alk-
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troscopy allowed the kinetic parameters for the conversion
of 1-ethoxy-1-octyne to be easily estimated (Ea = 105.4 kJ/
mol). Trapping of the in-situ-generated ketenes by alcohols
to give esters required the addition of a tertiary amine cata-
lyst to prevent competitive [2+2] addition of the ketene to the
alkoxyalkyne precursor.
oxyalkynes,[4] and their trapping with amines[5] or
alcohols[6] to provide amides and esters, respectively. Acyl-
ation, particularly of amines, is the most frequently used
reaction in pharmaceutical discovery,[7] and one of the most
used reactions in the synthesis of drug candidates.[8] It is
still often carried out using acyl chlorides, but this approach
has the disadvantages that moisture-sensitive precursors
must be handled, and halide by-products are formed. Al-
though a variety of other coupling reagents are used, most
are very atom inefficient.[9] The generation and trapping of
ketenes [Equation (1)] offers the prospect of a clean synthe-
sis of amides and esters where the only by-product is a low
molecular weight, volatile alkene. No work-up of the reac-
tion should be needed apart from removal of the solvent,
and the reaction would therefore also be suitable for incor-
poration into multistep flow-chemistry sequences. The pre-
cursor alkoxyalkynes are readily available.[10]
(1)
Results and Discussion
The required alkoxyalkyne precursors were produced
from readily available vinyl ethers in a two-pot sequence
(Scheme 1). Addition of bromine to ethyl or tert-butyl vinyl
ethers followed by in situ elimination of HBr using triethyl-
amine and aqueous work-up gave (Z)-β-bromo-vinyl ethers
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1 in reasonable yield.[11] Treatment of 1 with 2 equiv. of
LDA gave lithiated alkynyl ether 2, which was alkylated
with iodooctane to give the required alkynyl ethers 3a and
3b. The corresponding isopropoxy alkyne 3c was prepared
from trichloroethylene by isopropoxide substitution to give
4,[10a] followed by base-induced elimination to give lithiated
alkoxyalkyne 2, which was alkylated as before.[10a] It is
worth noting that lithiated alkoxyalkynes 2 are poorly reac-
tive towards alkylation.
Scheme 1. Synthesis of alkoxyalkynes 3; HMPA = hexamethylphos-
phoramide, DMPU = N,N-dimethylpropyleneurea, LDA = lith-
ium diisopropylamide.
Thermolysis experiments under flow conditions were car-
ried out using a Vapourtec R2+/R4 system with inline IR
spectroscopic monitoring using a sodium chloride flow cell
with 0.1 mm spacing in a Bruker alpha spectrometer.[12] The
Vapourtec system provides two pumped channels, each of
which could be switched between solvent and reagent, and
which include a six-port two-position rheodyne valve al-
lowing an injection loop to be switched into the flow. The
reaction-coil temperature is controlled using circulated
heated air. A liquid handler was used to collect samples for
reaction analysis (Figure 1, single pumped channel A
shown). Slugs of 2 mL volume containing alkoxyalkyne 3a,
3b, or 3c (0.5 mmol) and benzylamine (0.5 mmol) premixed
in toluene were introduced into a constant flow of toluene
(1 mL/min) using the injection loop, and then passed
Figure 1. Schematic representation of the flow set-up for a single-
channel sample-loop reaction with stainless steel reactor, inline IR
spectroscopy, and fraction collector for offline validation by NMR
spectroscopy.
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through a heated 10 mL capacity stainless steel tube of
1 mm internal diameter providing a residence time of ap-
proximately[13] 10 min. A 250 psi back-pressure regulator
was used to prevent boiling of the solvent. The ratios of the
starting alkoxyalkyne (i.e., 3a–3c) to the benzamide product
(i.e., 5) [Equation (2)] resulting from reaction at various
temperatures were determined by 1H NMR spectroscopy
after removal of the solvent from collected samples in
vacuo. The results are shown in Figure 2, and indicate a
temperature-dependent half-life of 10 min at approximately
155, 132, and 109 °C, where the alkoxy group (R1) is Et,
iPr, and tBu, respectively. This reflects the known order of
thermal instability of alkoxyalkanes 3a–3c.[4f] The optimum
temperatures for quantitative formation of 5 over 10 min,
were found to be approximately 180 °C (R1 = Et), 160 °C
(R1 = iPr), and 140 °C (R1 = tBu).
(2)
Figure 2. Thermolysis of alkoxyalkynes 3a (R1 = Et), 3b (R1 =
tBu), or 3c (R1 = iPr) under 10 min flow with trapping by benzyl-
amine (1 equiv.) in toluene.
A key advantage of flow systems is that both the reaction
time and the temperature may be varied in a series of easily
programmed automated experiments. Potentially, this al-
lows the kinetics of reactions to be readily established. For
the reaction of ethoxyalkyne 3a with benzylamine, variation
of the flow rate between 10 and 0.5 mL/min permitted resi-
dence times between 2 and 20 min, and we chose tempera-
tures between 150 and 180 °C for kinetic studies. The resi-
dence times were corrected for thermal expansion of the
solvent, and the precise control of the flow rate by the in-
strument was confirmed by independent volumetric mea-
surement of the collected samples. For the measurement of
temperature, we relied on a thermocouple in direct contact
with the stainless steel column. In all cases, the only prod-
ucts observed were the starting materials and the amide
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product (i.e., 5). In addition to 1H NMR spectroscopy, we
also used inline IR spectroscopy to monitor the conversion
of the alkoxyalkyne to the amide. The peak heights of the
respective calibrated absorption peaks at 2271 and
1683 cm–1 were used to calculate [3a]/[3a]0 (see Supporting
Information).
The expected first order kinetics were demonstrated (Fig-
ure 3), and the data from monitoring of the crude products
by 1H NMR spectroscopy and that obtained by inline mon-
itoring by IR spectroscopy were found to correlate well.
This confirms the validity of the latter method for quantify-
ing conversion. Arrhenius plots of the first-order rate con-
stants against the reciprocal of the temperature (Figure 3,
inset) showed excellent linearity, and allowed the activation
energy of the reaction to be estimated as 105.4 kJ/mol based
on IR spectroscopic monitoring, and 108.9 kJ/mol based on
offline NMR spectroscopy. The difference is probably due
to a slight nonlinearity in the calibration of the IR spectro-
scopic data. Thermal transfer calculations (see Supporting
Information) indicate that fluid in the stainless steel reactor
Figure 3. First order kinetics of the thermolysis of 1-ethoxydec-1-
yne (3a) and (inset) Arrhenius plots obtained from (a) inline moni-
toring by IR spectroscopy, and (b) offline monitoring by 1H NMR
spectroscopy. Rate constants: at 150 °C, k = 0.9310–3 (from IR
and NMR); at 160 °C, k = 1.7710–3 (IR) and 2.0110–3 (NMR);
at 170 °C, k = 3.3410–3 (IR) and 4.1210–3 (NMR); at 180 °C,
k = 6.8410–3 (IR) and 7.1210–3 (NMR).
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tubing reaches the bath temperature very quickly (within
the first 20 cm, i.e., within 2% of total length), and obser-
vation of the short cooling coil at the exit of the heated
reactor demonstrates that cool-down is also rapid. How-
ever, it is uncertain whether the rate of heat transfer from
the heated air to the coil is sufficient to prevent significant
cooling of the initial part of the reactor by entering solvent,
and, while the calculated Ea values are in reasonable agree-
ment with the activation energy of 121 kJ/mol determined
for the thermolysis of 1-ethoxyhept-1-yne in decalin by
Olsman,[4e] this may explain the deviation in the kinetic
plots observed at the fastest pumping speeds.
Having established optimum conditions for the forma-
tion of the ketene intermediate, we applied the in situ ketene
trapping reaction to the acylation of a range of amines
(Table 1). We chose to use 1-ethoxydec-1-yne (3a) and
ethoxyethyne (7) as ketene precursors, but given the com-
plete thermolysis of all the alkoxyalkyne precursors (i.e.,
3a–3c) shown in Figure 2, we suggest that isoproproxy- or
tert-butylalkyne substrates could be similarly used. For
these experiments, 3a was premixed with 6 as described
above, whereas 7 was delivered from a reagent bottle, and
then combined (in a mixing T) with a solution of amine 6
delivered from an injection loop, before passage through
the column at 180 °C (10 min residence time, vide supra).
To the best of our knowledge, the only reported examples
of ketenes generated from alkoxyalkynes being trapped by
alcohols are intramolecular.[6] Indeed, upon thermolysis of
3a in the presence of 1 equiv. benzyl alcohol under flow
conditions in toluene (180 °C, 10 min residence time), we
obtained ester 10a in only 28% yield, the major product
(72%) being the cyclobutenone (i.e., 11) resulting from
[2+2] cycloaddition between the intermediate ketene and 3a
[Equation (3)]. Given the efficiency of the trapping of the
ketene by amines, we sought to catalyse the reaction be-
tween the ketene and alcohols by using a tertiary amine.[14]
We were pleased to find that thermolysis of 3a in the pres-
ence of benzyl alcohol and pyridine (1 equiv. of each) gave
the desired ester (i.e., 10a) in an improved yield of 62%,
although substantial amounts of 11 (38%) were also
formed. Switching to the more nucleophilic 4-dimethyl-
aminopyridine (DMAP) reduced the amount of adduct 11
to 2.5%, and with 2 equiv. DMAP, 11 was undetectable.
Further investigation showed that 1 equiv. 1,4-diazabicyclo-
[2.2.2]octane (DABCO) gave only 0.5% of 11, and catalytic
quantities could be used with acceptable results (1.5 and
7% of 11 were formed with 0.5 and 0.1 equiv. DABCO,
respectively) indicating a reasonably fast turnover of the
amine. A reasonable catalytic cycle is shown in Scheme 2,
although a base-catalysed mechanism cannot be ruled out.
It seemed possible that an intermediate of structure 12
would be stable enough to allow trapping with the alcohol
after the thermolysis step was complete. Thus, to this end,
1-ethoxydec-1-yne (3a) and DMAP (1 or 2 equiv.) were sub-
jected to our usual thermolysis conditions (10 min, 180 °C),
and then the cooled flow was immediately combined with a
solution of benzyl alcohol. However, these conditions gave
mixtures of products 10a and 11 in 60:40 and 80:20 ratios,
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Table 1. Acylation of amines by in situ formation and trapping of
ketenes under flow conditions.[a]
R3R4NH 6 Product of reaction Product of reaction
of 6 with 3a of 6 with 7
(yield [%])[b] (yield [%])[b]
PhCH2NH2 5 (92) 9a (97)
tBuNH2 8b (96) 9b (99)
iPr2NH 8c (80) 9c (74)
Piperidine 8d (87) 9d (87)
Pyrrolidine 8e (84) 9e (88)
Morpholine 8f (86) 9f (93)
Cyclohexylamine 8g (85) 9g (97)
N-Methyl-N-cyclohexylamine 8h (93) 9h (92)
Dicyclohexylamine – –[c] 9i (89)
1,2,3,4-Tetrahydroisoquinoline – –[d] 9j (96)
PhNH2 8k (86) – –[d]
N-Allylaniline 8l (92) 9l (94)
Diallylamine 8m (87) 9m (89)
2-Aminopyridine 8n (72) 9n (82)
[a] For the synthesis of 5 and 8b–8n, the reagents were premixed in
the carrier solvent (toluene) before introduction into the solvent
flow via a sample loop. For the synthesis of 9a–9n, solutions of
ethoxyethyne and the amine trap 6 in toluene were mixed on the
flow system using a T-mixer. All reactions were conducted with a
residence time of 10 min at 180 °C. [b] Isolated yield of product of
95% purity by 1H NMR spectroscopy. [c] A mixture of 6, 8i, and
the cyclobutenone product of [2+2] cycloaddition[4d] between 3a
and the ketene intermediate was recovered. [d] Not carried out.
(3)
Scheme 2. Tertiary-amine-catalysed acylation of alcohols under
flow conditions.
from 1 and 2 equiv. DMAP, respectively. Since DMAP is
an efficient kinetic trap for the ketene, this result demon-
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strates the reversibility of trapping by the tertiary amine in
the absence of protonation of 12 by alcohol.
We tested the acylation with a variety of alcohols, and
we were pleased to obtain good isolated yields (Table 2),
except in the case of trapping with tert-butanol, which did
not give any of the ester product.
Table 2. Acylation of alcohols by in situ formation and trapping of
ketenes under flow conditions.[a]
ROH 13 Product Yield [%][b]
PhCH2OH 10a 71
Hexan-1-ol 10b 68
1-Geraniol 10c 77
2-Methylbutanol 10d 75
2-Propanol 10e 66
[a] Reagents were premixed in the carrier solvent (toluene) before
introduction into the solvent flow via a sample loop. All reactions
were conducted with a residence time of 10 min at 180 °C. [b] Iso-
lated yield of product of 95% purity by 1H NMR spectroscopy
following aqueous work-up and solvent removal in vacuo.
Conclusions
Flow chemistry, particularly using inline IR spectro-
scopic monitoring, provides a fast platform for both op-
timising, and acquiring basic kinetic data on reactions. The
in situ generation of ketenes by thermolysis of alkoxyalk-
ynes provides a clean method for the acylation of amines,
and, with the addition of a catalytic tertiary amine, also of
alcohols. The process is suitable for direct input of the prod-
ucts into a subsequent flow reaction as the only by-product
is a volatile alkene.
Experimental Section
General Methods: Batch synthesis reactions for the preparation of
3a–3c were carried out under an argon atmosphere using standard
Schlenk and syringe techniques. All glassware was dried at 160 °C
overnight before cooling in a sealed desiccator over silica gel before
use. CH2Cl2 was freshly distilled from CaH2. THF was freshly dis-
tilled under argon from sodium and benzophenone. NMR spectra
were recorded with a Bruker AV300 or DPX400 MHz spectrometer,
as stated. 1H chemical shifts are reported in ppm, referenced to
residual solvent signals. The following abbreviations are used to
designate multiplicity and may be compounded: s = singlet, d =
doublet, t = triplet, q = quartet, and m = multiplet. Coupling con-
stants, J, are measured in Hertz (Hz). 13C spectra are proton de-
coupled, and are referenced to solvent signals. 13C resonances are
reported as C, CH, CH2, or CH3 depending on the number of
directly attached protons (0, 1, 2, or 3, respectively), as determined
by DEPT experiments. Electron-impact-ionisation mass spectra
(EI) and chemical-ionisation (CI) mass spectra were recorded with
a ThermoQuest TraceMS GC–MS instrument. Electrospray mass
spectra (ES) were recorded in CH3CN or MeOH using a VG plat-
form quadrupole spectrometer. Accurate-mass spectra were re-
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corded with a VG analytical 70–250-SE double-focussing mass
spectrometer using electron-impact ionisation (EI) at 70 eV, or a
Bruker Apex III instrument using electrospray ionisation. LCMS
was carried out with a Waters ZQ machine, using an Acquity
UPLC BEH C18 column (50 mm2.1 mm i.d., 1.7 μm packing
diameter) at 40 °C. The UV detection was a summed signal from
wavelengths of 210 nm to 350 nm and alternate-scan positive and
negative electrospray was used. Scan range: 100–1000 Da, scan
time: 0.27 s, and inter-scan delay: 0.10 s. Values of m/z are reported
in atomic mass units (Da). Infrared spectra for compound charac-
terisation were run as neat films with a Thermo Nicolet 380 FTIR
spectrometer with a Smart Orbit Goldengate attachment. Absorp-
tions are given in wavenumbers (cm–1). Peaks are recorded as s
(strong), m (medium), w (weak), sh (shoulder), and br (broad).
Continuous-Flow Methods: All reactions were carried out on a Va-
pourtec R2+/R4 system with a tubular stainless steel reactor of
1 mm internal diameter and 10 mL capacity using a 250 psi back-
pressure regulator to prevent the boiling of solvents. In situ IR
spectroscopic measurements were recorded with a Bruker ALPHA
FTIR Universal Sampling Module at room temperature using a
Harrick DLC 2™ Demountable Liquid Flow Cell with sodium
chloride windows and 100 μm spacers. Full details of inline IR
analysis are provided in the Supporting Information. A Gilson
sample handler was used to collect fractions for offline analysis.
Continuous-Flow Procedure A: For the synthesis of decanamides 5
and 8b–8n: 1-Ethoxydec-1-yne (3a) was premixed with an equiva-
lent amount of amine 6 in toluene (2 mL) before insertion into a
continuous flow of toluene (1 mL/min) via an injection loop. The
mixture then passed through a stainless steel tube (10 mL; 1 mm
i.d.) heated at 180 °C, after which it was collected. The solvent was
removed to give the product. Where necessary (8l and 8n), the prod-
uct was purified by chromatography on silica gel using a gradient
of ethyl acetate in cyclohexane.
Continuous-Flow Procedure B: For the synthesis of acetamides 9a–
9n: A solution of amine 6 (2.0 mmol) in toluene (2.5 mL) was used
to fill a 2 mL injection loop (which thus contained a maximum of
1.6 mmol amine). The amine solution plug was inserted into a flow
of toluene (0.5 mL/min), which was then combined with a bottle-
fed plug of ethoxyacetylene (0.8 m solution in toluene; 2 mL,
1.6 mmol), also flowing at 0.5 mL/min, using a mixing T to give a
combined flow rate of 1 mL/min. The solution was passed through
a stainless steel tube (10 mL; 1 mm i.d.) heated at 180 °C, after
which it was collected. The solvent was removed to give the prod-
uct. The products were purified by chromatography on silica gel
using a gradient of ethyl acetate in cyclohexane as eluent.
Continuous-Flow Procedure C: For the synthesis of esters 10a–10e:
1-Ethoxydec-1-yne (3a; 0.5 mmol, 0.0911 g), alcohol 13 (0.5 mmol),
and DMAP (1.0 mmol, 0.122 g) were dissolved in toluene (1.6 mL).
This solution was inserted into a continuous flow of toluene (1 mL/
min) via a sample loop, and then passed through a stainless steel
tube (10 mL; 1 mm i.d.) heated at 180 °C. The solution containing
the product was collected, washed with HCl (aq.), water, and brine,
and dried (MgSO4). The solvent was removed to give the product.
1-Ethoxydec-1-yne (3a): nBuLi (2.5 m solution in hexanes; 42 mL,
0.105 mol) was added to a solution of diisopropylamine (14.8 mL,
0.1 mol) in THF (8 mL) under argon at 0 °C. A solution of (Z)-
1-bromo-2-ethoxyethene (7.55 g, 0.050 mol) in THF (58 mL) was
added dropwise at –70 °C, and then the mixture was warmed to
room temp. and stirred for 2 h. The solution was recooled to
–70 °C, and HMPA (18.3 mL, 0.105 mol) was added dropwise. The
solution was stirred for 30 min, then iodooctane (6.64 mL,
0.045 mol) was added, and the solution was warmed to room temp.
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and stirred for 30 h. The reaction mixture was quenched with water
(200 mL), diethyl ether (100 mL) was added, and the organic phase
was separated and dried with MgSO4. Concentration under re-
duced pressure gave a dark oil (8.59 g), which was purified on basic
alumina (grade III) with hexane elution to give compound 3a
(4.18 g, 51%) as a colourless oil. IR: ν˜ = 2925 (m), 2271 (s), 1222
(s) cm–1. 1H NMR (300 MHz, CDCl3): δ = 4.00 (q, J = 7.1 Hz, 2
H), 2.10 (t, J = 6.8 Hz, 2 H), 1.44 (quint, J = 6.8 Hz, 2 H), 1.33 (t,
J = 7.1 Hz, 3 H), 1.1–1.5 (m, 10 H), 0.88 (t, J = 6.5 Hz, 3 H) ppm.
13C NMR (75 MHz, CDCl3): δ = 89.26 (C), 73.72 (CH2), 37.32
(C), 31.84 (CH2), 29.24 (CH2), 29.13 (CH2), 28.81 (CH2), 22.63
(CH2), 17.18 (CH2), 14.29 (CH2), 14.07 (CH3), 14.03 (CH3) ppm.
1-tert-Butoxydec-1-yne (3b): nBuLi (2.5 m solution in hexanes;
39.3 mL, 0.098 mol) was added to THF (7.2 mL) and diisopropyl-
amine (13.85 mL, 0.098 mL) at 0 °C under argon. A solution of 1-
bromo-2-tert-butoxyethene (8.32 g, 0.047 mol) in THF (45 mL) was
then added dropwise to the solution at –70 °C, and the resulting
mixture was warmed to room temp. and stirred for 2 h. The solu-
tion was then recooled to –70 °C. HMPA (17.1 mL, 0.098 mol) was
added, and the solution was stirred for 30 min. Iodooctane
(6.21 mL, 0.042 mol) was then added, and the solution was stirred
at room temp. for 30 h. The reaction was quenched with water
(200 mL), and the mixture was extracted with diethyl ether
(100 mL). The organic phase was dried over MgSO4. Concentra-
tion under reduced pressure gave a dark oil (10.04 g). Purification
on basic alumina (grade III) with hexane elution gave compound
3b (5.20 g, 53%) as a colourless oil. IR: ν˜ = 2925 (m), 2262 (m),
1159 (s) cm–1. 1H NMR (400 MHz, CDCl3): δ = 2.12 (t, J = 6.6 Hz,
2 H), 1.52–1.23 (m, 12 H), 1.35 (s, 9 H), 0.88 (t, J = 6.6 Hz, 3 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 85.60 (C), 83.62 (C), 40.00
(C), 31.91 (CH2), 29.98 (CH2), 29.33 (CH2), 29.20 (CH2), 28.88
(CH2), 26.83 (CH2), 26.83 (CH2), 22.67 (CH3), 17.45 (CH2), 13.98
(CH3) ppm.
1-Isopropoxydec-1-yne (3c): nBuLi (1.6 m solution in hexanes;
10.25 mL, 16.14 mmol) was cooled to –30 °C, and THF (20 mL)
was added. The mixture was cooled further to –70 °C, then a solu-
tion of 1,2-dichloro-2-isopropoxyethene (1.251 g, 8.07 mmol) in
THF (40 mL) was added dropwise. The mixture was stirred for
15 min at –70 °C, then a solution of DMPU (1.946 mL,
16.14 mmol) in THF (10 mL) was added. The solution was stirred
for a further 15 min, and then it was warmed to –10 °C and stirred
for 10 min before recooling to –78 °C. A solution of 1-iodooctane
(1.457 mL, 8.07 mmol) in THF (20 mL) was added dropwise. The
resulting solution was stirred at room temperature for 3 d. The re-
action was quenched with brine (20 mL), the layers were separated,
and the organic phase washed with brine (20 mL). The aqueous
layer was extracted with diethyl ether (3 30 mL), and the com-
bined organic extracts were dried with MgSO4. The solvent was
removed in vacuo to give a brown oil (3.068 g). Purification was
carried out by flash-column chromatography (RediSep Alumina,
Basic, 240 g, 100% cyclohexane) with a FlashMaster Personal puri-
fication platform to give compound 3c (0.809 g, 51%) as a colour-
less oil. IR: ν˜ = 2979 (s), 2268 (m), 1231 (s), 1143 (s), 1101 (m),
925 (m) cm–1. 1H NMR (400 MHz, CDCl3): δ = 4.20 (sept, J =
6.2 Hz, 1 H), 2.13 (t, J = 6.9 Hz, 2 H), 1.52–1.23 (m, 18 H), 0.89
(t, J = 6.5 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 87.93
(C), 80.51 (CH), 38.58 (C), 31.87 (CH2), 29.86 (CH2), 29.26 (CH2),
29.16 (CH2), 28.85 (CH2), 22.66 (CH2), 21.25 (CH3), 17.34 (CH2),
14.07 (CH3) ppm.
N-Benzyldecanamide (5):[15] According to continuous-flow pro-
cedure A, but dissolving the reagents in toluene (8 mL) and using
a 10 mL injection loop, benzylamine (0.218 mL, 2 mmol) gave com-
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pound 5 (0.480 g, 92%) as a white solid, m.p. 74–75 °C. IR: ν˜ =
3291 (m), 2916 (m), 1631 (s), 1554 (m), 694 (s) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 7.39–7.26 (m, 5 H), 5.77 (br. s, 1 H, NH),
4.44 (d, J = 5.5 Hz, 2 H), 2.21 (dd, J = 7.3, 7.3 Hz, 2 H), 1.66
(quint, J = 7.6 Hz, 2 H), 1.41–1.23 (m, 12 H), 0.89 (t, J = 6.8 Hz,
3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 172.95 (C), 138.42
(C), 128.67 (CH), 127.79 (CH), 127.45 (CH), 43.56 (CH2), 36.63
(CH2), 31.84 (CH2), 29.43 (CH2), 29.32 (CH2), 29.30 (CH2), 29.23
(CH2), 25.76 (CH2), 22.64 (CH2), 14.08 (CH3) ppm. HRMS (ESI):
calcd. for C17H28NO [M + H]+ 262.2165; found 262.2161.
N-(tert-Butyl)decanamide (8b): According to continuous-flow pro-
cedure A, tert-butylamine (1.0 mmol, 105.1 μL) gave compound 8b
(0.218 g, 96%) as a white solid, m.p. 33–35 °C. IR: ν˜ = 3307 (m),
2959 (m), 1644 (s), 732 (s) cm–1. 1H NMR (300 MHz, CDCl3): δ =
5.25 (br. s, 1 H, NH), 2.07 (t, J = 7.6 Hz, 2 H), 1.59 (quint, J =
7.1 Hz, 2 H), 1.34 (s, 9 H), 1.23–1.37 (m, 12 H), 0.87 (t, J = 6.8 Hz,
3 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 172.51 (C), 50.99 (C),
37.75 (CH2), 31.83 (CH2), 29.43 (CH2), 29.35 (CH2), 29.25 (CH2),
29.21 (CH2), 28.83 (CH3), 25.78 (CH2), 22.64 (CH2), 14.07 (CH3)
ppm. HRMS (ESI): calcd. for C14H30NO [M + H]+ 228.2322;
found 228.2318.
N,N-Diisopropyldecanamide (8c):[16] According to continuous-flow
procedure A, diisopropylamine (1.0 mmol, 141.1 μL) gave com-
pound 8c (0.204 g, 80%) as a pale yellow oil. IR: ν˜ = 2923 (m),
1638 (s), 1438 (m) cm–1. 1H NMR (300 MHz, CDCl3): δ = 3.92 (m,
1 H), 3.43 (m, 1 H), 2.22 (t, J = 8.1 Hz, 2 H), 1.56 (quint, J =
7.1 Hz, 2 H), 1.32 (d, J = 7.1 Hz, 6 H), 1.19–1.29 (m, 12 H), 1.15
(d, J = 6.6 Hz, 6 H), 0.83 (t, J = 6.7 Hz, 3 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 171.95 (C), 48.12 (CH), 45.36 (CH), 35.31
(CH2), 31.74 (CH2), 29.37 (CH3), 29.17 (CH2), 25.36 (CH2), 22.52
(CH2), 20.90 (CH2), 20.58 (CH2), 13.95 (CH3) ppm. MS (ESI+):
m/z (%) = 278.3 (100) [M + Na]+, 533.5 (35) [2M + Na]+.
1-(Piperidin-1-yl)decan-1-one (8d):[17] According to continuous-flow
procedure A, piperidine (1.0 mmol, 98.8 μL) gave compound 8d
(0.208 g, 87%) as a pale yellow oil. IR: ν˜ = 2923 (s), 1635 (s), 1434
(m) cm–1. 1H NMR (300 MHz, CDCl3): δ = 3.53 (dd, J = 5.6,
5.6 Hz, 2 H), 3.38 (dd, J = 5.6, 5.6 Hz, 2 H), 2.30 (t, J = 7.7 Hz, 2
H), 1.19–1.36 (m, 8 H), 1.19–1.35 (m, 12 H), 0.87 (t, J = 6.1 Hz, 3
H) ppm. 13C NMR (75 MHz, CDCl3): δ = 171.49 (C), 46.68 (CH2),
42.54 (CH2), 33.46 (CH2), 31.83 (CH2), 29.50 (CH2), 29.42 (CH2),
29.23 (CH2), 26.55 (CH2), 25.56 (CH2), 25.47 (CH2), 24.56 (CH2),
22.61 (CH2), 14.04 (CH3) ppm. MS (ESI+): m/z (%) = 262.3 (100)
[M + Na]+, 502.5 (10) [2M + Na]+.
1-(Pyrrolidin-1-yl)decan-1-one (8e): According to continuous-flow
procedure A, pyrrolidine (0.5 mmol, 41.1 μL) gave compound 8e
(0.098 g, 86%) as a brown oil. IR: ν˜ = 2922 (m), 1640 (s), 1425 (s)
cm–1. 1H NMR (300 MHz, CDCl3): δ = 3.39 (dt, J = 13.5, 6.8 Hz,
4 H), 2.21 (t, J = 7.5 Hz, 2 H), 1.74–1.98 (m, 4 H), 1.60 (quint, J
= 7.3 Hz, 2 H), 1.13–1.34 (m, 12 H), 0.83 (t, J = 6.6 Hz, 3 H) ppm.
13C NMR (75 MHz, CDCl3): δ = 171.72 (C), 46.48 (CH2), 45.43
(CH2), 34.73 (CH2), 31.74 (CH2), 29.41 (CH2), 29.35 (CH2), 29.16
(CH2), 26.01 (CH2), 24.84 (CH2), 24.30 (CH2), 22.53 (CH2), 13.97
(CH3) ppm. HRMS (ESI): calcd. for C14H27NNaO [M + Na]+
248.1985; found 248.1986.
1-Morpholinodecan-1-one (8f):[18] According to continuous-flow
procedure A, morpholine (0.5 mmol, 43.3 μL) gave compound 8f
(0.101 g, 84%) as a pale yellow oil. IR: ν˜ = 2922 (m), 1645 (s), 1426
(m), 1115 (s) cm–1. 1H NMR (300 MHz, CDCl3): δ = 3.49–3.63 (m,
6 H), 3.36–3.44 (m, 2 H), 2.24 (t, J = 7.7 Hz, 2 H), 1.55 (quint, J
= 7.2 Hz, 2 H), 1.12–1.32 (m, 12 H), 0.81 (t, J = 6.5 Hz, 3 H) ppm.
13C NMR (75 MHz, CDCl3): δ = 171.74 (C), 66.80 (CH2), 66.53
(CH2), 45.91 (CH2), 41.70 (CH2), 32.97 (CH2), 31.71 (CH2), 29.30
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(CH2), 29.12 (CH2), 25.12 (CH2), 22.49 (CH2), 13.94 (CH3) ppm.
MS (ESI+): m/z (%) = 264.3 (100) [M + Na]+, 296.3 (42) [M + Na
+ MeOH]+.
N-Cyclohexyldecanamide (8g): According to continuous-flow pro-
cedure A, cyclohexylamine (1.0 mmol, 114.7 μL) gave compound
8g (0.215 g, 85%) as a white solid, m.p. 71–73 °C. IR: ν˜ = 3297 (m),
2917 (m), 1637 (s), 1546 (s) cm–1. 1H NMR (400 MHz, CDCl3): δ
= 5.17 (br. s, 1 H, NH), 3.66 (m, 1 H), 2.05 (t, J = 8.0 Hz, 2 H),
1.76–1.90 (m, 2 H), 1.63 (dt, J = 14.0, 4.0 Hz, 2 H), 1.40–1.57 (m,
4 H), 0.93–1.38 (m, 16 H), 0.81 (t, J = 6.8 Hz, 3 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 172.22 (C), 48.08 (CH), 37.24 (CH2), 33.39
(CH2), 31.95 (CH2), 29.79 (CH2), 29.54 (CH2), 29.45 (CH2), 29.36
(CH2), 25.99 (CH2), 25.66 (CH2), 24.97 (CH2), 22.75 (CH2),
14.10 (CH3) ppm. MS (ESI+): m/z (%) = 317.3 (100) [M + Na +
MeCN]+.
N-Cyclohexyl-N-methyldecanamide (8h): According to continuous-
flow procedure A, N-methyl-N-cyclohexylamine (0.5 mmol,
65.2 μL) gave compound 8h (0.124 g, 93%) as a yellow oil. IR: ν˜ =
2923 (s), 1640 (s), 1450 (m) cm–1. A rotameric mixture was ob-
served by NMR spectroscopy. Additional rotamer peaks are indi-
cated *. 1H NMR (300 MHz, CDCl3): δ = 4.42 (tt, J = 11.0, 3.0 Hz,
1 H), 3.51 (* tt, J = 11.5, 3.0 Hz, 1 H), 2.79 (s, 3 H), 2.76 (* s, 3
H), 2.29 (t, J = 7.5 Hz, 2 H), 2.25 (* t, J = 7.5 Hz, 2 H), 0.97–1.87
(m, 20 H), 0.85 (t, J = 6.2 Hz, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 172.60 (C*), 172.56 (C), 56.55 (CH), 51.96 (CH*),
34.14 (CH2), 33.53 (CH2), 31.78 (CH2), 30.91 (CH2*), 29.82 (CH2),
29.45 (CH2), 29.37 (CH2), 29.18 (CH2), 26.94 (CH3), 25.78 (CH2),
25.57 (CH2), 25.24 (CH2*), 25.10 (CH2), 22.56 (CH2), 13.98 (CH3)
ppm. HRMS (ESI): calcd. for C17H34NO [M + H]+ 268.2635;
found 268.2629.
N-Phenyldecanamide (8k):[15] According to continuous-flow pro-
cedure A, aniline (1.0 mmol, 91.2 μL) gave compound 8k (0.212 g,
86%) as a white solid, m.p. 63–64 °C. IR: ν˜ = 3313 (m), 2916 (m),
1655 (s), 1600 (s), 1538 (s) cm–1. 1H NMR (300 MHz, CDCl3): δ =
7.55 (br. s, 1 H, NH), 7.45 (d, J = 8.0 Hz, 2 H), 7.21 (t, J = 8.0 Hz,
2 H), 7.00 (t, J = 7.3 Hz, 1 H), 2.26 (t, J = 7.6 Hz, 2 H), 1.63
(quint, J = 7.3 Hz, 2 H), 1.11–1.32 (m, 12 H), 0.80 (t, J = 6.7 Hz,
3 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 171.69 (C), 138.04
(C), 128.85 (CH), 124.06 (CH), 119.86 (CH), 37.73 (CH2), 31.80
(CH2), 29.41 (CH2), 29.35 (2 CH2), 29.24 (CH2), 25.65 (CH2), 22.61
(CH2), 14.06 (CH3) ppm. MS (ESI+): m/z (%) = 495.5 (20) [2M +
Na]+, 517.4 (4) [2M + Na]+.
N-Allyl-N-phenyldecanamide (8l): According to continuous-flow
procedure A, N-allylaniline (0.5 mmol, 67.8 μL) gave, after purifi-
cation on silica, compound 8l (0.132 g, 92%) as a yellow oil. IR: ν˜
= 2923 (m), 1657 (s), 699 (s) cm–1. 1H NMR (300 MHz, CDCl3): δ
= 7.39–6.93 (m, 5 H), 6.02–5.66 (m, 1 H), 5.26–4.87 (m, 2 H), 4.21
(d, J = 6.2 Hz, 2 H), 1.96 (t, J = 7.3 Hz, 2 H), 1.47 (m, 2 H), 0.95–
1.38 (m, 12 H), 0.80 (t, J = 6.4 Hz, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 173.19 (C), 143.17 (C), 133.77 (CH), 129.85 (CH),
128.72 (CH), 128.13 (CH), 117.92 (CH2), 52.56 (CH2), 34.74 (CH2),
32.22 (CH2), 29.75 (CH2), 29.69 (CH2), 29.64 (CH2), 29.61 (CH2),
25.87 (CH2), 23.01 (CH2), 14.75 (CH3) ppm. HRMS (ESI): calcd.
for C19H30NO [M + H]+ 288.2322; found 288.2313.
N,N-Diallyldecanamide (8m):[19] According to continuous-flow pro-
cedure A, diallylamine (0.5 mmol, 61.7 μL) gave compound 8m
(0.109 g, 87%) as a pale yellow oil. IR: ν˜ = 3298 (br.), 2918 (s),
1641 (s), 1552 (s) cm–1. 1H NMR (300 MHz, CDCl3): δ = 5.65–
5.81 (m, 2 H), 5.03–5.20 (m, 4 H), 3.95 (m, 2 H), 3.84 (m, 2 H),
2.27 (t, J = 7.7 Hz, 2 H), 1.61 (quint, J = 7.1 Hz, 2 H), 1.16–1.36
(m, 12 H), 0.84 (t, J = 6.6 Hz, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 173.00 (C), 133.36 (CH), 132.91 (CH), 116.87 (CH2),
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116.31 (CH2), 49.00 (CH2), 47.65 (CH2), 32.88 (CH2), 31.73 (CH2),
29.32 (3 CH2), 29.13 (CH2), 25.821 (CH2), 22.51 (CH2), 13.95
(CH3) ppm. HRMS (ESI): calcd. for C16H30NO [M + H]+
252.2327; found 252.2316.
N-(Pyridin-2-yl)decanamide (8n): According to continuous-flow
procedure A, 2-aminopyridine (0.5 mmol, 0.047 g) gave, after puri-
fication on silica, compound 8n (0.089 g, 72%) as a white solid,
m.p. 38–40 °C. IR: ν˜ = 3255 (m), 2923 (m), 1697 (m), 1431 (s) cm–1.
1H NMR (300 MHz, CDCl3): δ = 8.33 (br. s, 1 H, NH), 8.27 (m,
2 H), 7.71 (td, J = 8.0, 2.0 Hz, 1 H), 7.03 (td, J = 6.0, 1.5 Hz, 2
H), 2.39 (t, J = 7.76 Hz, 2 H), 1.72 (quint, J = 7.4 Hz, 2 H), 1.26
(m, 12 H), 0.88 (t, J = 6.8 Hz, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 172.42 (C), 151.19 (C), 147.87 (CH), 138.82 (CH),
119.92 (CH), 114.71 (CH), 38.11 (CH2), 32.22 (CH2), 29.78 (CH2),
29.71 (CH2), 29.61 (CH2), 29.60 (CH2), 25.78 (CH2), 23.02 (CH2),
14.45 (CH3) ppm. HRMS (ESI): calcd. for C15H25N2O [M + H]+
249.1967; found 249.1961.
Benzylacetamide (9a):[20] According to continuous-flow procedure
B, benzylamine gave compound 9a (0.231 g, 97%) as a white solid,
m.p. 54–56 °C. IR: ν˜ = 3285 (br. s), 1636 (s), 1544 (s), 692 (s) cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.31–7.21 (m, 5 H), 7.08 (br. s,
1 H, NH), 4.31 (d, J = 5.8 Hz, 2 H), 1.91 (s, 3 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 170.23 (C), 138.22 (C), 128.26 (CH), 127.37
(CH), 126.98 (CH), 43.20 (CH2), 22.63 (CH3) ppm. MS (ESI+): m/z
(%) = 191.2 (100) [M + H + MeCN]+.
N-(tert-Butyl)acetamide (9b):[21] According to continuous-flow pro-
cedure B, tert-butylamine gave compound 9b (0.183 g, 99%) as a
white solid, m.p. 96–97 °C. IR: ν˜ = 3284 (br. s), 1641 (m), 1555 (s),
1223 (s), 606 (s) cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.72 (br.
s, 1 H, NH), 1.85 (s, 3 H), 1.28 (s, 9 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 169.51 (C), 50.92 (C), 28.62 (CH3), 24.27 (CH3) ppm.
MS (ESI+): m/z (%) = 157.2 (89) [M + H + MeCN]+.
N,N-Diisopropylacetamide (9c):[22] According to continuous-flow
procedure B, diisopropylamine gave compound 9c (0.187 g, 74%)
as a yellow oil. IR: ν˜ = 2967 (m), 1633 (s), 1442 (m), 1324 (s) cm–1.
1H NMR (400 MHz, CDCl3): δ = 3.81 (sept, J = 6.7 Hz, 1 H), 3.44
(m, 1 H), 1.98 (s, 3 H), 1.28 (d, J = 6.8 Hz, 12 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 169.45 (C), 49.07 (CH), 45.24 (CH), 23.70
(CH3), 20.74 (CH3), 20.41 (CH3) ppm. MS (ESI+): m/z (%) = 144.2
(43) [M + H]+, 185.3 (29) [M + MeCN + H]+, 207.3 (100) [M +
Na + MeCN]+, 208.3 (12) [M + Na + MeCN + H]+, 309.3 (11)
[2M + Na]+.
1-(Piperidin-1-yl)ethanone (9d):[23] According to continuous-flow
procedure B, piperidine gave compound 9d (0.178 g, 87%) as a yel-
low oil. IR: ν˜ = 2933 (m), 1627 (s), 1322 (s), 1264 (m) cm–1. 1H
NMR (400 MHz, CDCl3): δ = 3.42 (t, J = 5.6 Hz, 2 H), 3.28 (t, J
= 5.6 Hz, 2 H), 1.96 (s, 3 H), 1.53 (m, 2 H), 1.46 (m, 2 H), 1.41
(m, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 168.42 (C), 47.16
(CH2), 42.18 (CH2), 26.15 (CH2), 25.23 (CH2), 24.20 (CH2), 21.17
(CH3) ppm. MS (ESI+): m/z (%) = 169.2 (100) [M + H + MeCN]
+, 191.3 (36) [M + Na + MeCN]+, 192.2 (4) [M + H + Na +
MeCN]+, 255.3 (25) [2M + H]+, 277.3 (5) [2M + Na]+.
1-(Pyrrolidin-1-yl)ethanone (9e):[23] According to continuous-flow
procedure B, pyrrolidine gave compound 9e (0.159 g, 88%) as a
yellow oil. IR: ν˜ = 3455 (br. s), 1619 (s), 1422 (s) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 3.20 (t, J = 6.8 Hz, 4 H), 1.80 (s, 3 H),
1.73 (quint, J = 6.7 Hz, 2 H), 1.63 (quint, J = 6.7 Hz, 2 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 168.48 (C), 46.61 (CH2), 44.92
(CH2), 25.55 (CH2), 24.03 (CH2), 21.91 (CH3) ppm. MS (ESI+):
m/z (%) = 155.2 (100) [M + H + MeCN]+, 177.2 (50) [M + Na +
MeCN]+.
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1-Morpholinoethanone (9f):[24] According to continuous-flow pro-
cedure B, morpholine gave compound 9f (0.191 g, 93%) as a yellow
oil. IR: ν˜ = 3501 (br. s), 1629 (s), 1425 (s), 1248 (s), 1111 (s), 1021
(m) cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.60 (t, J = 5.0 Hz, 2
H), 3.59 (t, J = 5.0 Hz, 2 H), 3.52 (t, J = 5.0 Hz, 2 H), 3.39 (t, J =
5.0 Hz, 2 H), 2.01 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ
= 168.90 (C), 66.61 (CH2), 66.37 (CH2), 46.46 (CH2), 41.55 (CH2),
20.94 (CH3) ppm. LCMS (HpH): m/z (%) = 129.9 (100) [M +
H]+.
N-Cyclohexylacetamide (9g):[25] According to continuous-flow pro-
cedure B, cyclohexylamine gave compound 9g (0.218 g, 97%) as a
white solid, m.p. 104–105 °C. IR: ν˜ = 3220 (br. s), 1635 (s), 1399
(s) cm–1. 1H NMR (400 MHz, CDCl3): δ = 6.23 (br. s, 1 H), 3.63
(ttd, J = 11.5, 3.9, 7.3 Hz, 1 H), 1.86 (s, 3 H), 1.84–1.00 (m, 10 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 169.12 (C), 48.06 (CH),
32.86 (CH2), 25.53 (CH2), 24.74 (CH2), 23.15 (CH3) ppm. LCMS
(HpH): m/z (%) = 142.1, 100 [M + H]+.
N-Cyclohexyl-N-methylacetamide (9h):[26] According to con-
tinuous-flow procedure B, N-methyl-N-cyclohexylamine gave com-
pound 9h (0.229 g, 92%) as a yellow oil. IR: ν˜ = 2927 (m), 1632
(s), 1505 (m), 1021 (m) cm–1. A rotameric mixture was observed by
NMR spectroscopy. 1H NMR (400 MHz, CDCl3): δ = 4.21 (tt, J
= 11.5, 4.5 Hz, 0.5 H), 3.29 (tt, J = 11.5, 4.5 Hz, 0.5 H), 2.63 (s,
1.5 H), 2.58 (s, 1.5 H), 1.90 (s, 1.5 H), 1.86 (s, 1.5 H), 1.70–0.80
(m, 10 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 169.45 (C),
169.36 (C), 57.03 (CH), 51.43 (CH), 30.33 (CH2), 29.69 (CH3),
29.22 (CH2), 26.34 (CH3), 25.28 (CH2), 25.13 (CH2), 25.08 (CH3),
24.78 (CH3) ppm. MS (ESI+): m/z (%) = 156.2 (42) [M + H]+.
N,N-Dicyclohexylacetamide (9i): According to continuous-flow
procedure B, dicyclohexylamine gave compound 9i (0.319 g, 89%)
as a white solid, m.p. 101–103 °C. IR: ν˜ = 12931 (m), 1624 (s), 1310
(m) cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.34 (t, J = 6.1 Hz, 1
H), 2.34 (m, 1 H), 1.80 (s, 3 H), 1.85–1.00 (m, 10 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 169.52 (C), 55.59 (CH), 31.31 (CH2),
30.12 (CH2), 26.55 (CH2), 26.03 (CH2), 25.31 (CH2), 25.22 (CH2),
24.04 (CH3) ppm. HRMS (ESI): calcd. for C14H26NO [M + H]+
224.2009; found 224.2006.
1-[3,4-Dihydroisoquinolin-2(1H)-yl]ethanone (9j):[27] According to
continuous-flow procedure B, 1,2,3,4-tetrahydroisoquinoline
(1.0 mmol, 0.134 g) gave compound 9j (0.168 g, 96%) as a white
solid, m.p. 44–46 °C. IR: ν˜ = 3019 (w), 1640 (m), 1426 (m), 727 (s)
cm–1. A rotameric mixture was observed by NMR spectroscopy.
Additional rotamer peaks are indicated *. 1H NMR (400 MHz,
CDCl3): δ = 7.28–7.13 (m, 4 H), 7.28–7.13 (* m, 4 H), 4.78 (s, 2
H), 4.67 (* s, 2 H), 3.87 (* t, J = 5.9 Hz, 2 H), 3.73 (t, J = 5.9 Hz,
2 H), 2.96 (t, J = 5.9 Hz, 2 H), 2.90 (* t, J = 5.9 Hz, 2 H), 2.24 (s,
3 H), 2.23 (* s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 169.41
(C), 169.32 (C*), 135.01 (C*), 133.96 (C), 133.45 (C), 132.50 (C*),
128.86 (CH*), 128.21 (CH), 126.83 (CH), 126.58 (CH), 126.53
(CH*), 126.45 (CH*), 126.27 (CH), 125.95 (CH*), 48.01 (CH2*),
44.01 (CH2), 43.93 (CH2*), 39.41 (CH2*), 29.39 (CH2), 28.45
(CH2*), 21.87 (CH3*), 21.61 (CH3) ppm. LCMS: m/z (%) = 176.1
(100) [M + H]+.
N-Allyl-N-phenylacetamide (9l):[28] According to continuous-flow
procedure B, N-allylaniline gave compound 9l (0.264 g, 94%) as a
pale brown solid, m.p. 41–43 °C. IR: ν˜ = 1641 (s), 1392 (s), 1273
(s), 704 (s) cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.31–7.04 (m,
5 H), 5.75 (tdd, J = 6.4, 16.8, 10.2 Hz, 1 H), 4.97 (m, 2 H), 4.19
(d, J = 6.3 Hz, 2 H), 1.75 (s, 3 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 169.70 (C), 142.74 (C), 132.91 (CH), 128.29 (CH),
127.80 (CH), 127.59 (CH), 117.40 (CH2), 51.70 (CH2), 22.39 (CH3)
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ppm. MS (ESI+): m/z (%) = 176.2 (100) [M + H]+, 198.2 (4) [M +
Na]+, 217.2 (54) [M + MeCN + H]+.
N,N-Diallylacetamide (9m):[29] According to continuous-flow pro-
cedure B, diallylamine gave compound 9m (0.198 g, 89%) as a yel-
low oil. IR: ν˜ = 3081 (w), 1636 (s), 1410 (m), 1245 (m), 920 (m)
cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.66 (tdd, J = 6.4, 16.8,
10.2 Hz, 1 H), 5.64 (tdd, J = 6.4, 16.8, 10.2 Hz, 1 H), 5.05 (m, 4
H), 3.87 (d, J = 6.0 Hz, 2 H), 3.76 (m, 2 H), 1.98 (s, 3 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 170.20 (C), 133.01 (CH), 132.45
(CH), 116.87 (CH), 116.23 (CH), 49.69 (CH2), 47.45 (CH2),
22.63 (CH3) ppm. MS (ESI+): m/z (%) = 181.3 (100) [M + H +
MeCN]+, 279.3 (8) [2M + H]+.
N-(Pyridin-2-yl)acetamide (9n):[30] According to continuous-flow
procedure B, 2-aminopyridine gave compound 9n (0.178 g, 81.7%)
as a white solid, m.p. 62–64 °C. IR: ν˜ = 3180 (w), 1687 (s), 1577
(s), 1528 (s), 1430 (s), 1298 (s), 774 (s) cm–1. 1H NMR (400 MHz,
CDCl3): δ = 9.39 (br. s, 1 H, NH), 8.29 (d, J = 5.0 Hz, 1 H), 8.16
(d, J = 8.1 Hz, 1 H), 7.70 (t, J = 7.9 Hz, 1 H), 7.03 (t, J = 5.5 Hz,
1 H), 2.19 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 169.00
(C), 151.82 (C), 147.35 (CH), 138.48 (CH), 119.58 (CH), 114.45
(CH), 24.50 (CH3) ppm. LCMS: m/z (%) = 137.0 (100) [M + H]+.
Benzyldecanoate (10a):[31] According to continuous-flow procedure
C, benzylalcohol gave compound 10a (0.093 g, 71%) as a pale yel-
low oil. IR: ν˜ = 2923 (s), 1731 (s), 1151 (s) cm–1. 1H NMR
(300 MHz, CDCl3): δ = 7.24–7.31 (m, 5 H), 5.04 (s, 2 H), 2.28 (t,
J = 7.7 Hz, 2 H), 1.50–1.63 (m, 2 H), 1.18 (m, 12 H), 0.80 (t, J =
6.7 Hz, 3 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 173.10 (C),
136.12 (C), 128.51 (CH), 128.13 (2 CH), 66.03 (CH2), 34.32 (CH2),
29.38 (CH2), 29.22 (3 CH2), 29.10 (CH2), 24.94 (CH2), 22.64 (CH2),
14.09 (CH3) ppm. MS (CI): m/z (%) = 263.2 (2.5) [M + H]+.
Octyldecanoate (10b):[32] According to continuous-flow procedure
C, 1-hexanol gave compound 10b (0.087 g, 68%) as a colourless
oil. IR: ν˜ = 2995 (m), 1734 (s), 1170 (m), 732 (s) cm–1. 1H NMR
(300 MHz, CDCl3): δ = 4.06 (t, J = 6.7 Hz, 2 H), 2.29 (t, J =
7.5 Hz, 2 H), 1.54–1.71 (m, 4 H), 1.18–1.47 (m, 18 H), 0.82–0.96
(m, 6 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 173.99 (C), 64.36
(CH2), 34.39 (CH2), 31.84 (CH2), 31.42 (CH2), 29.41 (CH2), 29.25
(CH2), 29.13 (CH2), 28.61 (CH2), 25.59 (CH2), 25.02 (CH2), 22.64
(CH2), 22.53 (CH2), 14.07 (CH3), 13.97 (CH3) ppm. MS (ESI–):
m/z (%) = 171.1 (100) [C10H19O2]–.
(E)-2,3,7-Trimethylocta-2,6-dien-1-yl Decanoate (10c): According
to continuous-flow procedure C, 1-geraniol gave compound 10c
(0.119 g, 77%) as a pale yellow oil. IR: ν˜ = 2923 (s), 1735 (s), 1161
(s) cm–1. 1H NMR (300 MHz, CDCl3): δ = 5.35 (t, J = 7.1 Hz, 1
H), 5.09 (t, J = 6.1 Hz, 1 H), 4.60 (d, J = 7.1 Hz, 2 H), 2.30 (t, J
= 7.6 Hz, 2 H), 2.02–2.15 (m, 4 H), 1.71 (s, 3 H), 1.69 (s, 3 H),
1.58–1.66 (m, 5 H), 1.22–1.35 (m, 12 H), 0.89 (t, J = 6.4 Hz, 3 H)
ppm. 13C NMR (75 MHz, CDCl3): δ = 173.93 (C), 142.09 (C),
131.80 (C), 123.76 (CH), 118.43 (CH), 61.16 (CH2), 39.53 (CH2),
34.41 (CH2), 31.86 (CH2), 29.42 (CH2), 29.26 (CH2), 29.15 (CH2),
26.30 (CH2), 25.66 (CH3), 25.02 (CH2), 22.65 (CH2), 17.68 (CH3),
16.45 (CH3), 14.08 (CH3) ppm. HRMS (ES+): calcd. for
C20H36NaO2 [M + Na]+ 331.2608; found 331.2615.
2-Methylbutyl Decanoate (10d): According to continuous-flow pro-
cedure C, 2-methylbutanol gave compound 10d (0.071 g, 75%) as
a colourless oil. IR: ν˜ = 2924 (s), 1736 (s), 1155 (s), 732 (m), 696
(s) cm–1. 1H NMR (300 MHz, CDCl3): δ = 3.95 (dd, J = 11.0,
6.2 Hz, 1 H), 3.69 (dd, J = 10.6, 7.0 Hz, 1 H), 2.23 (t, J = 7.5 Hz,
2 H), 1.46–1.72 (m, 3 H), 1.01–1.44 (m, 14 H), 0.74–0.92 (m, 9 H)
ppm. 13C NMR (75 MHz, CDCl3): δ = 174.05 (C), 68.87 (CH2),
34.41 (CH), 34.12 (CH2), 31.84 (CH2), 29.41 (CH2), 29.24 (CH2),
www.eurjoc.org © 2015 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 2015, 1491–14991498
29.15 (CH2), 26.03 (CH2), 25.03 (CH2), 22.64 (CH2), 16.37 (CH3),
14.07 (CH3), 11.19 (CH) ppm. HRMS (ES+): calcd. for
C15H30NaO2 [M + Na]+ 265.2138; found 265.2142.
Isopropyl Decanoate (10e):[33] According to continuous-flow pro-
cedure C, isopropanol gave compound 10e (0.071 g, 66%) as a yel-
low oil. IR: ν˜ = 2924 (s), 1732 (s), 1108 (s) cm–1. 1H NMR
(300 MHz, CDCl3): δ = 5.01 (sept, J = 6.3 Hz, 1 H), 2.26 (t, J =
7.5 Hz, 2 H), 1.54–1.69 (m, 2 H), 1.25–1.35 (m, 12 H), 1.23 (d, J
= 6.2 Hz, 6 H), 0.88 (t, J = 6.7 Hz, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 173.46 (C), 67.29 (CH), 34.73 (CH2), 31.84 (CH2),
29.41 (CH2), 29.24 (2 CH2), 29.10 (CH2), 25.03 (CH2), 22.64 (CH2),
21.84 (CH3), 14.09 (CH3) ppm. MS (CI): m/z (%) = 214.2 (2) [M],
215.2 (67) [M + H]+, 232.3 (100) [M + NH4]+.
3-Ethoxy-2,4-dioctylcyclobut-2-enone (11): Using a 10 mL injection
loop, a solution of 1-ethoxydec-1-yne (3a; 0.364 g, 2.0 mmol) in
toluene (8 mL) was inserted into a continuous flow of toluene
(1 mL/min), which then passed through a stainless steel tube
(10 mL; 1 mm i.d.) heated at 180 °C, after which it was collected.
The solvent was removed to give the crude product. Purification
by column chromatography (basic alumina grade III eluting with
hexane/diethyl ether, 3:1) gave compound 11 (0.320 g, 95%) as a
colourless oil. IR: ν˜ = 2929 (m), 1615 (s), 1323 (m) cm–1. 1H NMR
(300 MHz, CDCl3): δ = 4.26–4.38 (m, 2 H), 3.35 (t, J = 5.8 Hz, 1
H), 2.05 (t, J = 7.1 Hz, 2 H), 1.60 (m, 2 H), 1.43 (t, J = 7.1 Hz, 3
H), 1.16–1.38 (m, 24 H), 0.87 (t, J = 6.6 Hz, 6 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 190.86 (C), 179.15 (C), 121.04 (C), 68.12
(CH), 58.85 (CH2), 31.83 (2 CH2), 29.72 (CH2), 29.47 (CH2), 29.40
(CH2), 29.28 (CH2), 29.22 (CH2), 28.50 (CH2), 28.23 (CH2), 26.54
(CH2), 22.63 (2 C), 15.16 (CH3), 14.07 (CH3) ppm. HRMS (ES+):
calcd. for C22H41O2 [M + H]+ 337.3101; found 337.3105. Com-
pound 11 is a known compound that has previously been charac-
terised by boiling point and refractive index.[4e]
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